Rebel Allergan investors demand C-suite shakeup after 'half-hearted' strategic review

5th June 2018 Uncategorised 0

After Allergan announced it’s planning to sell its women’s health and infectious disease units, some investors still aren’t happy. They’re so upset, in fact, that they’re calling for a shakeup at the top—and that could mean a CEO switch.

More: Rebel Allergan investors demand C-suite shakeup after 'half-hearted' strategic review
Source: fierce